Drug intelligence / Profile preview

Yudan Rongxin Pills

Development stage: Unknown
Lead developer: Shanghai Yudan Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Yudan Rongxin Pills (玉丹荣心丸) is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Shanghai Yudan Pharmaceutical. It is primarily indicated and approved for the treatment of viral myocarditis, including pediatric cases. The drug is also studied for its role in immune regulation and its therapeutic mechanisms in acute myocardial infarction. As a multi-component herbal medication, it is administered orally in pill form and is designed to provide cardioprotective effects and modulate immune system activity through various biological pathways inherent to its constituent herbs.

Brand names: Yudan Rongxin Pills玉丹荣心丸
Other names: 玉丹荣心丸Rongxin Pills

Beyond the preview

Go deeper on Yudan Rongxin Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yudan Rongxin Pills.

Explore the full profile